Good MorningEquities slipped again on Thursday with the S&P 500 falling more than 1.0% at the close of the session. The move is driven by a growing fear the US economy has been broken and will result in a serious recession over the next year or so. The day's move took the S&P to the lowest level in two weeks and has it on track to move even lower over the coming days.
Next week the market will be on high alert for housing data in the form of Housing Starts and Permits and Existing Home Sales as well as the Index of Leading Indicators. The latest housing data suggests a 30% YOY decline in housing activity and there is a chance the figure could grow with the August data. As far as the leading indicators go, that index has been running negative for four consecutive months and is expected to show another decline in US economic activity. Featured: Sell these "safe" blue chips immediately (Ad) 
|
Healthcare | |
U.S. stocks suffered their biggest one-day drop in more than two years on Tuesday.
Oil & gas companies as well as auto manufacturers have managed to move higher.
At the individual stock level, there have also been some interesting contrarian movers
Yes, the market’s strong Septemb... Read the Full Story |
|
From Our Partners | | Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. | | Watch the full story and see the verified track record for yourself |
|
Healthcare | |
What’s gone right and what is still off about TDOC stock
TDOC stock went “to the moon” for most of 2020 and the early part of 2021.
Today, TDOC stock is trading at a five-year low.
One of the more intriguing pandemic stocks in my opinion was Teladoc Health (NYSE: TDOC). T... Read the Full Story |
|
Markets | |
You've likely heard of the company Colgate-Palmolive, particularly if you're a big fan of that brand of toothpaste. However, the Colgate-Palmolive Company (NYSE: CL) produces so many more products than just toothpaste. Let's take a look at some facts about Colgate-Palmolive Company as well as some... Read the Full Story |
|
From Our Partners | | Moderna's stock doubled in a single day after its cancer vaccine hit key Phase 3 goals, and Merck jumped too. But according to a former Steve Cohen fund manager, the next big opportunity is not Moderna or Merck.
It is a different kind of company tied to a technology already backed by Elon Musk, Sam Altman, Jeff Bezos, and Peter Thiel. Nvidia's Jensen Huang says it will have a dramatic impact on daily life, while Anthropic's CEO believes it could unlock a century of medical progress in just ten years.
Nature Magazine estimates its potential value at $367 trillion globally, and it is already rolling out across the United States. | | Click here to learn about this new era of medical technology |
|
Healthcare | |
The stock returned 58.36% in the past three months
On a fundamental basis, strong sales and earnings growth has bolstered its strength
Now guiding to overall revenue growth of 18-21%
There are plenty of steps and partner companies involved with producing any product within the pharmaceutica... Read the Full Story |
|
Finance | |
To be fair, Arbor Realty Trust (NYSE: ABR) is not a stock but a REIT but yes, its 10% yielding units are worth it. Yes, I know that REITs come with tax implications that make them less attractive for average investors and in regular accounts but they are an investment vehicle with many attractive ... Read the Full Story |
|
From Our Partners | | Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | | Discover the gold income fund before the next payout date |
|
Markets | |
RF Industries (NASDAQ: RFIL) is no megacorporation but it is a company investors should tune into. It manufactures a wide assortment of RF and related componentry used by communications industries of all stripes. The business is being supported by the push toward 5G as well, and it is in business ... Read the Full Story |
|
Communication Services | | Since the fall from grace began just over a year ago, shares of streaming giant Netflix (NASDAQ: NFLX) have dropped as much as 75%. These past few months have been good to them though, and heading into the last quarter of the year they’re up about 35% from the multi-year lows they hit in May a... Read the Full Story |
|
Consumer Discretionary | |
Around six or seven years ago, a new gas station operated by Murphy USA (NYSE: MUSA) opened across the street from a Super Walmart (NYSE: WMT) not far from where I live in Santa Fe, New Mexico.
Since then, I’ve noticed Murphy gas stations springing up throughout the U.S. While the company ... Read the Full Story |
|
Industrials | |
If you’re an investor in 3M (NYSE:MMM) you’re aware of the perfect storm that’s swirling around the company and its stock. The company got a lift from being a supplier of essential materials for first responders during the pandemic.
That halo is long since gone. The company now... Read the Full Story |
|
Markets | | We’ve all seen those commercials where someone has to get up frequently during the night to urinate; Axonics (NASDAQ: AXNX) is a company whose products address that problem.
The stock rallied to a high on Monday then pulled back along with the broader market.
The Irvine, California company... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH. | | View Today's Stock Pick |
|
